scholarly journals Long-term retrospective evaluation of short dental implant success and associated risk factors

2018 ◽  
Vol 29 ◽  
pp. 370-370
Author(s):  
Guzin Neda Erbasar Hasanoglu ◽  
Ramiz Can Erbasar ◽  
Turgay Peyami Hocaoglu
Keyword(s):  
Risk Factors ◽  
Dental Implant ◽  
Retrospective Evaluation ◽  
Associated Risk Factors

Low-calorie sweeteners and human health: a rapid review of systematic reviews

2020 ◽  
Author(s):  
Lesley Andrade ◽  
Kirsten M Lee ◽  
Allison C Sylvetsky ◽  
Sharon I Kirkpatrick
Keyword(s):  
Risk Factors ◽  
Systematic Reviews ◽  
Chronic Conditions ◽  
Disease Risk ◽  
Rapid Review ◽  
Anthropometric Measures ◽  
Low Calorie ◽  
Associated Risk Factors ◽  
Low Calorie Sweetener

Abstract Introduction Low-calorie sweeteners are increasingly prevalent in the food supply and their consumption has increased in recent decades. Although low-calorie sweeteners approved for use are considered safe from a toxicological perspective, their short- and long-term impacts on chronic disease risk remain uncertain. The aim of this review was to summarize the evidence from systematic reviews on low-calorie sweetener use and chronic conditions and risk factors in children and adults. Methods MEDLINE and the Cochrane Database of Systematic Reviews were searched to identify systematic reviews of randomized and nonrandomized studies that considered low-calorie sweeteners in relation to type 2 diabetes, cardiovascular disease, cancer, anthropometric measures, hypertension, hyperglycemia, hyperlipidemia, insulin resistance, and dental caries. Data were extracted from 9 reviews deemed of moderate or high quality on the basis of AMSTAR-2. Results Narrative synthesis suggested inconsistent evidence on low-calorie sweetener use in relation to chronic conditions and associated risk factors, with nonrandomized studies suggesting positive associations and randomized studies suggesting negative or no associations. Conclusion Continued research on the long-term health impacts of low-calorie sweeteners across all life stages is warranted.

Prevalence of hypertension and associated risk factors in people with long-term spinal cord injury living in the Netherlands

2016 ◽  
Vol 39 (9) ◽  
pp. 919-927 ◽  
Author(s):  
Jacinthe J. E. Adriaansen ◽  
Yvonne Douma-Haan ◽  
Floris W. A. van Asbeck ◽  
Casper F. van Koppenhagen ◽  
Sonja de Groot ◽  
...  
Keyword(s):  
Risk Factors ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
The Netherlands ◽  
Cord Injury ◽  
Associated Risk Factors

scholarly journals Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study

2020 ◽  
Vol 183 (4) ◽  
pp. 427-437 ◽  
Author(s):  
I C M Pelsma ◽  
N R Biermasz ◽  
A M Pereira ◽  
W R van Furth ◽  
N M Appelman-Dijkstra ◽  
...  
Keyword(s):  
Risk Factors ◽  
Growth Hormone ◽  
Vertebral Fracture ◽  
Follow Up Study ◽  
Total Incidence ◽  
Point Increase ◽  
Associated Risk Factors ◽  
Spine Radiographs

Objective: Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) excess results in both reversible and irreversible musculoskeletal damage, including increased vertebral fracture (VF) risk. The prevalence of VFs is approximately 60% in controlled acromegaly patients, and these VFs can progress in time. We aimed to identify the course of VFs in a cohort of acromegaly patients in long-term remission and their associated risk factors during prolonged follow-up. Methods: Thirty-one patients with acromegaly (49% female, median age 60 years (IQR 53–66)), who were in remission for ≥2 years, were included in this longitudinal, prospective, follow-up study. Spine radiographs of vertebrae Th4 to L4 were assessed for VFs using the Genant score, at baseline, after 2.6 years and 9.1 years. Progression was defined as either a new fracture or a ≥1-point increase in Genant score. Results: The prevalence of VF at baseline was 87% (27/31 patients). Progression of VFs was observed in eleven patients (35.5%) during the 9.1-year follow-up period, with a total incidence rate of 65.5 per 1000 person years (males 59.8 per 1000 person years vs females 71.6 per 1000 person years). Patients treated with surgery or radiotherapy had a higher risk of VF progression in this cohort (P = 0.030). Conclusions: In this cohort of long-term, well-controlled acromegalic patients, the prevalence and progression of VFs was high, showing that the deleterious effects of GH and IGF-1 excess on bone persist despite achievement of longstanding remission.

Emergence Delirium

2018 ◽  
Author(s):  
Arvind Chandrakantan ◽  
Mehernoor Watcha
Keyword(s):  
Risk Factors ◽  
Rating Scales ◽  
Emergence Agitation ◽  
Short Term ◽  
Emergence Delirium ◽  
Prevention And Treatment ◽  
Associated Risk Factors ◽  
Uniform Treatment ◽  
Parents And Caregivers

Emergence agitation/emergence delirium is a self-limited, postanesthesia complication occurring in anywhere between 10% and 80% of children. It is important to recognize that emergence agitation/emergence delirium represents a continuum of increasing severity. While there are no long-term sequelae as a result of emergence delirium, the short-term consequences can be trying for parents and caregivers alike. While no uniform “treatment” exists for emergence delirium, there are various approaches in treating and preventing the condition. This chapter defines the features of emergence delirium and the associated risk factors; describes the different rating scales for measuring emergence delirium and the differences between them, and lastly discusses the measures for the prevention and treatment of pediatric emergence delirium.

Long-Term Outcomes and Associated Risk Factors of Post-Hospitalization Dialysis-Dependent Acute Kidney Injury Patients

Nephron ◽  
2017 ◽  
Vol 137 (2) ◽  
pp. 105-112 ◽  
Author(s):  
Ajay S. Rathore ◽  
Tushar Chopra ◽  
Jennie Z. Ma ◽  
Wenjun Xin ◽  
Emaad M. Abdel-Rahman
Keyword(s):  
Risk Factors ◽  
Acute Kidney Injury ◽  
Kidney Injury ◽  
Long Term Outcomes ◽  
Associated Risk Factors

scholarly journals Long-Haul COVID-19: Putative Pathophysiology, Risk Factors, and Treatments

2020 ◽  
Author(s):  
Shin Jie Yong
Keyword(s):  
Risk Factors ◽  
Support Groups ◽  
Cell Activation ◽  
Chronic Fatigue ◽  
Mast Cell Activation ◽  
Multiple Sources ◽  
Fatigue Syndrome ◽  
Adults And Children ◽  
Associated Risk Factors

Long-haul COVID-19 illness first gained widespread recognition among social support groups and later in scientific and medical communities. This illness is mysterious as it affects COVID-19 survivors at all levels of disease severity, even younger adults and children. While the precise definition may be lacking, the defining symptoms are fatigue, dyspnea, and headache that last for months after hospital discharge. The less typical symptoms may include cognitive impairments, chest and joint pains, myalgia, smell and taste dysfunctions, cough, mood changes, and gastrointestinal and cardiac issues. Presently, there is limited literature discussing the possible pathophysiology, risk factors, and treatments in long-haul COVID-19, which the current review aims to address. In brief, long-haul COVID-19 may be driven by long-term lung and brain damage and unresolved inflammation from multiple sources. The associated risk factors may include female sex, more than five early symptoms, early dyspnea, and specific biomarkers like D-dimer. While only rehabilitation training has been useful for long-haul COVID-19, therapeutics repurposed from mast cell activation syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, and pulmonary fibrosis also hold potential. In sum, this review hopes to provide the current understanding of what is known about long-haul COVID-19.

Sign in / Sign up

Export Citation Format

Share Document